The Proteome of Circulating Large Extracellular Vesicles in Diabetes and Hypertension

Int J Mol Sci. 2023 Mar 3;24(5):4930. doi: 10.3390/ijms24054930.

Abstract

Hypertension and diabetes induce vascular injury through processes that are not fully understood. Changes in extracellular vesicle (EV) composition could provide novel insights. Here, we examined the protein composition of circulating EVs from hypertensive, diabetic and healthy mice. EVs were isolated from transgenic mice overexpressing human renin in the liver (TtRhRen, hypertensive), OVE26 type 1 diabetic mice and wild-type (WT) mice. Protein content was analyzed using liquid chromatography-mass spectrometry. We identified 544 independent proteins, of which 408 were found in all groups, 34 were exclusive to WT, 16 were exclusive to OVE26 and 5 were exclusive to TTRhRen mice. Amongst the differentially expressed proteins, haptoglobin (HPT) was upregulated and ankyrin-1 (ANK1) was downregulated in OVE26 and TtRhRen mice compared with WT controls. Conversely, TSP4 and Co3A1 were upregulated and SAA4 was downregulated exclusively in diabetic mice; and PPN was upregulated and SPTB1 and SPTA1 were downregulated in hypertensive mice, compared to WT mice. Ingenuity pathway analysis identified enrichment in proteins associated with SNARE signaling, the complement system and NAD homeostasis in EVs from diabetic mice. Conversely, in EVs from hypertensive mice, there was enrichment in semaphroin and Rho signaling. Further analysis of these changes may improve understanding of vascular injury in hypertension and diabetes.

Keywords: cardiovascular; diabetes; extracellular vesicles; hypertension; microparticles; microvesicles; vascular.

MeSH terms

  • Animals
  • Diabetes Mellitus, Experimental*
  • Extracellular Vesicles*
  • Humans
  • Hypertension*
  • Mice
  • Mice, Transgenic
  • Proteome
  • Vascular System Injuries*

Substances

  • Proteome

Grants and funding